
    
      Evaluate the effectiveness of Boston Scientific (BSC)'s LV MSP (Left Ventricular MultiSite
      Pacing) feature in the Resonate family of CRT-D devices and confirm safety in a post approval
      study when used in accordance with its approved labeling.
    
  